GERINDA THERAPEUTICS, INC

Address

1001 SHELDON DR
CARY, NC, 27513-2012

Information

DUNS: 9695452
# of Employees: 0

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. New ultra-selective kinase inhibitors for the treatment of AML

    Amount: $248,481.00

    DESCRIPTION (provided by applicant): Acute Myeloid Leukemia (AML) accounts for a high percentage of all adult leukemia cases. Although most patients at first respond well to conventional chemotherapy, ...

    SBIRPhase I2012Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government